Internal Medicine News - Abciximab during elective PCI gave diabetics no benefit
February 15, 2005 -- NEW ORLEANS -- Treatment with abciximab failed to improve the outcomes of patients with diabetes who underwent elective percutaneous coronary...
American Family Physician - Tirofiban vs. Abciximab for Platelet Inhibition
February 1, 2002 -- Use of platelet glycoprotein IIb/IIIa inhibitors has become more widespread in percutaneous coronary revascularization because of their demonstrated...
PR Newswire Europe - Patient Enrollment Permanently Discontinued in Investigational Clinical Trial of REOPRO(R) (abciximab) for Acute Ischemic Stroke.
October 28, 2005 -- HORSHAM, Pennsylvania and INDIANAPOLIS, October 28 /PRNewswire/ -- Centocor, Inc. and Eli Lilly and Company announced today that patient...
PR Newswire Europe - Patient Enrollment Temporarily Suspended in Investigational Clinical Trial of REOPRO(R) (abciximab) for Acute Ischemic Stroke.
October 4, 2005 -- HORSHAM, Pennsylvania and INDIANAPOLIS, October 4 /PRNewswire/ -- Centocor, Inc. and Eli Lilly and Company announced today that enrollment in...
Internal Medicine News - Abciximab improves stent outcomes in diabetics with MIs
February 15, 2002 -- ANAHEIM, CALIF. -- The ADMIRAL study strengthens the case for using abciximab in conjunction with stent procedures for diabetic patients with acute...
Internal Medicine News - Abciximab may give stroke patients 6-hour time window for treatment
April 15, 2003 -- PHOENEX -- The frustratingly small window of time in which ischemic strokes can be effectively treated may be opening a crack wider with the...
American Family Physician - Stenting Plus Abciximab Reduces Damage After MI - Brief Article
June 15, 2002 -- Following myocardial infarction, one drawback of several reperfusion strategies is the potential to activate platelet and inflammatory mechanisms,...
HealthDay - Mixed Results for Anti-Clotting Drugs in Heart Attacks
May 21, 2008 -- Emergency treatment with two different anti-clotting drugs doesn't help much when someone who suffers a heart attack can't get a quick artery-opening...
Market Wire - Medicure Comments on Positive AGGRASTAT Results Presented at the American College of Cardiology Annual Scientific Session
April 3, 2008 -- Medicure Inc. (TSX: MPH)(AMEX: MCU), a cardiovascular-focused biopharmaceutical company, today commented on the positive results of two large...
Canadian Corporate News - Medicure Comments on Positive AGGRASTAT Results Presented at the American College of Cardiology Annual Scientific Session.
April 3, 2008 -- WINNIPEG, MANITOBA, Apr 3, 2008 (Marketwire via COMTEX) -- Medicure Inc. (TSX:MPH)(AMEX:MCU), a cardiovascular-focused biopharmaceutical company,...
